KDR and neoplasm: (2) Commonly used TKI drugs all exert the targeted therapeutic effect of VEGFR, which can not only regulate tumor blood vessels, but also serve as an effective immunomodulatory molecule, affecting TAM, MDSC, Treg cells and effector T cells (Fukumura et al., 2018).